Elevated Plasma Soluble Triggering Receptor Expressed on Myeloid Cells-1 Level in Patients with Acute Coronary Syndrome (ACS): A Biomarker of Disease Severity and Outcome.
Shachaf ShiberVitaly KliminskiKatia OrvinIftach SagyMordehay VaturiRan KornowskiMichael DrescherYair MoladPublished in: Mediators of inflammation (2021)
Plasma sTREM-1 levels are significantly elevated in patients with ACS and might serve as a biomarker differentiating ACS from NSCP in the ED as well as an inflammatory biomarker for coronary artery disease severity and outcome.